phosphoserine has been researched along with Cognition Disorders in 3 studies
Phosphoserine: The phosphoric acid ester of serine.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While a potential causal factor in Alzheimer's disease (AD), brain insulin resistance has not been demonstrated directly in that disorder." | 1.38 | Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. ( Arnold, SE; Arvanitakis, Z; Bakshi, KP; Bennett, DA; Fuino, RL; Han, LY; Kawaguchi, KR; Kazi, H; Samoyedny, AJ; Schneider, JA; Stucky, A; Talbot, K; Trojanowski, JQ; Wang, HY; Wilson, RS; Wolf, BA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Careaga, M | 1 |
| Hansen, RL | 1 |
| Hertz-Piccotto, I | 1 |
| Van de Water, J | 1 |
| Ashwood, P | 1 |
| Qu, N | 1 |
| Zhou, XY | 1 |
| Han, L | 1 |
| Wang, L | 1 |
| Xu, JX | 1 |
| Zhang, T | 1 |
| Chu, J | 1 |
| Chen, Q | 1 |
| Wang, JZ | 1 |
| Zhang, Q | 1 |
| Tian, Q | 1 |
| Talbot, K | 1 |
| Wang, HY | 1 |
| Kazi, H | 1 |
| Han, LY | 1 |
| Bakshi, KP | 1 |
| Stucky, A | 1 |
| Fuino, RL | 1 |
| Kawaguchi, KR | 1 |
| Samoyedny, AJ | 1 |
| Wilson, RS | 1 |
| Arvanitakis, Z | 1 |
| Schneider, JA | 1 |
| Wolf, BA | 1 |
| Bennett, DA | 1 |
| Trojanowski, JQ | 1 |
| Arnold, SE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open Label, Single Site, 48 Week, Randomised Controlled Trial Evaluating the Safety and Efficacy of Exenatide Once-weekly in the Treatment of Patients With Multiple System Atrophy[NCT04431713] | Phase 2 | 50 participants (Anticipated) | Interventional | 2020-09-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for phosphoserine and Cognition Disorders
| Article | Year |
|---|---|
Increased anti-phospholipid antibodies in autism spectrum disorders.
Topics: Antibodies, Antiphospholipid; beta 2-Glycoprotein I; Cardiolipins; Child; Child Behavior Disorders; | 2013 |
Combination of PPT with LiCl Treatment Prevented Bilateral Ovariectomy-Induced Hippocampal-Dependent Cognition Deficit in Rats.
Topics: Animals; Cell Nucleus; Cognition Disorders; Estrogen Receptor alpha; Female; Glycogen Synthase Kinas | 2016 |
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Brain; Cerebellar Cortex; Cognition D | 2012 |